-+ 0.00%
-+ 0.00%
-+ 0.00%

TG Therapeutics Announces Presentation Dates For BRIUMVI Data On Relapsing Forms Of Multiple Sclerosis

Benzinga·03/06/2026 12:34:10
Listen to the news

TGTX announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of Neurology (AAN) 2026 annual meeting, being held April 18 - 22, 2026